Drug Information

Drug General Information
Drug ID
D0S2UG
Former ID
DIB004250
Drug Name
Selegiline
Synonyms
Selegiline (transdermal, Parkinson's/depression)
Drug Type
Small molecular drug
Indication Major depressive disorder [ICD9: 296.2, 296.3, 710.0; ICD10:F32, F33, M32] Approved [522265], [541748]
Company
Syntropharma
Structure
Download
2D MOL

3D MOL
Formula
C13H17N
InChI
InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1
InChIKey
MEZLKOACVSPNER-GFCCVEGCSA-N
PubChem Compound ID
26757
PubChem Substance ID
9454, 7980587, 8169367, 11113910, 11466580, 11467700, 11486280, 14772861, 14797266, 17397820, 26752066, 29293584, 46509459, 47662432, 47810884, 48259382, 48259383, 48334634, 48416534, 49698549, 49880108, 50104720, 50104721, 50139277, 53789537, 57310317, 61127936, 80766630, 85787938, 85788262, 89449661, 92308745, 92310005, 94569169, 99300917, 103252336, 104298196, 104829538, 117391911, 117884350, 128586172, 134337870, 134339187, 134989154, 137001242, 142170639, 160964372, 175267457, 176484098, 176484773
Target and Pathway
Target(s) Amine oxidase [flavin-containing] B Target Info Inhibitor [543639]
BioCyc Pathway Superpathway of tryptophan utilization
Tryptophan degradation via tryptamine
Dopamine degradation
Putrescine degradation III
Noradrenaline and adrenaline degradation
KEGG Pathway Glycine, serine and threonine metabolism
Arginine and proline metabolism
Histidine metabolism
Tyrosine metabolism
Phenylalanine metabolism
Tryptophan metabolism
Drug metabolism - cytochrome P450
Metabolic pathways
Serotonergic synapse
Dopaminergic synapse
Cocaine addiction
Amphetamine addiction
Alcoholism
PANTHER Pathway Adrenaline and noradrenaline biosynthesis
5-Hydroxytryptamine degredation
Dopamine receptor mediated signaling pathway
Pathway Interaction Database Alpha-synuclein signaling
WikiPathways Tryptophan metabolism
Dopamine metabolism
Phase 1 - Functionalization of compounds
References
Ref 522265ClinicalTrials.gov (NCT00640159) Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease. U.S. National Institutes of Health.
Ref 541748(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6639).
Ref 543639(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2490).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.